TerrAscend (TRSSF) and Its Peers Critical Contrast

TerrAscend (OTCMKTS:TRSSFGet Rating) is one of 32 public companies in the “Agricultural production – crops” industry, but how does it contrast to its competitors? We will compare TerrAscend to similar companies based on the strength of its analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends.

Analyst Recommendations

This is a summary of recent ratings and price targets for TerrAscend and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TerrAscend 0 3 5 0 2.63
TerrAscend Competitors 56 137 440 23 2.66

TerrAscend presently has a consensus target price of $3.57, suggesting a potential upside of 100.37%. As a group, “Agricultural production – crops” companies have a potential upside of 63.97%. Given TerrAscend’s higher possible upside, analysts clearly believe TerrAscend is more favorable than its competitors.

Profitability

This table compares TerrAscend and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TerrAscend -143.67% -8.24% -3.88%
TerrAscend Competitors -199.08% -18.48% -11.40%

Insider and Institutional Ownership

0.0% of TerrAscend shares are owned by institutional investors. Comparatively, 28.7% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 44.3% of TerrAscend shares are owned by company insiders. Comparatively, 21.5% of shares of all “Agricultural production – crops” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares TerrAscend and its competitors revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
TerrAscend $210.42 million $3.11 million -1.33
TerrAscend Competitors $1.63 billion $92.12 million 7.26

TerrAscend’s competitors have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

TerrAscend competitors beat TerrAscend on 7 of the 12 factors compared.

TerrAscend Company Profile

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.